Wedbush cuts Xenon Pharmaceuticals price target to $55
Wedbush lowered its price target on Xenon Pharmaceuticals to $55.00 from $71.00, according to ratings actions cited by Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.